Medical Polymer Market worth $71.92 billion by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 17, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Medical Polymer Market is projected to reach USD 71.92 billion by 2031 from USD 48.27 billion in 2026, at a CAGR of 8.3% during the forecast period.

Browse 335 market data tables and 54 figures spread through 274 pages and an in-depth TOC on the 'Medical Polymer Market - Global Forecast to 2031'

Medical Polymer Market Size & Forecast:

• Market Size Available for Years: 2023-2031
• 2026 Market Size: USD 48.27 billion
• 2031 Projected Market Size: USD 71.92 billion
• CAGR (2026-2031): 8.3%

Medical Polymer Market Trends & Insights:

• The global medical polymer market is growing due to increasing demand for advanced medical devices, minimally invasive procedures, drug delivery systems, medical consumables, and biocompatible and high-performance polymer materials. The market in Asia Pacific is supported by expanding healthcare infrastructure, increasing medical device manufacturing, rising healthcare expenditure, growing patient populations, and investments in pharmaceutical and healthcare manufacturing across China, India, Japan, South Korea, and Southeast Asia. In Europe, the market is supported by established healthcare systems, stringent medical device regulations, increasing demand for advanced medical technologies, and the adoption of specialty and high-performance polymers in medical applications. North America is witnessing steady growth, supported by technological advancements in medical devices, adoption of minimally invasive and implantable devices, demand for high-performance medical materials, and investments in healthcare and medical device manufacturing. Meanwhile, South America and the Middle East & Africa are experiencing gradual market development, supported by improving healthcare infrastructure, increasing healthcare expenditure, expanding access to medical devices and healthcare products, and investments in healthcare and medical manufacturing capabilities.
• By region, Asia Pacific accounted for 30.3% of the medical polymer market in 2025, supported by expanding healthcare infrastructure, growing medical device manufacturing, rising healthcare expenditure, and rising demand for medical devices and healthcare products across China, India, Japan, and South Korea.
• By manufacturing technology, the extrusion tubing segment is estimated to grow at a CAGR of 8.5% between 2026 and 2031, supported by its ability to produce continuous, precise, and dimensionally consistent polymer components. Increasing demand for medical tubing in catheters, fluid management systems, drug delivery devices, and other minimally invasive applications is contributing to segment growth.
• By type, the medical Plastics segment is estimated to grow at a CAGR of 8.4% between 2026 and 2031, owing to their lightweight nature, durability, chemical resistance, flexibility, and suitability for sterilization. Their increasing use in medical instruments, devices, packaging, consumables, and other healthcare applications is supporting demand.
• By application, the medical instruments & devices segment is anticipated to record a CAGR of 8.9% during the forecast period, driven by the increasing use of medical polymers in surgical instruments, diagnostic devices, drug delivery systems, catheters, and other healthcare equipment. Growing adoption of minimally invasive procedures and increasing demand for lightweight, durable, and biocompatible components are further supporting segment growth.
• BASF SE (Germany), SABIC (Saudi Arabia), and Covestro AG (Germany) were identified as key players in the medical polymer market, given their strong market share and product footprint.
• Trinseo, Kraton Corporation, and Mitsubishi Chemical Advanced Materials, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=211635984

There are various factors affecting the medical polymer market. There is a growing demand for lightweight, durable, and biocompatible materials for medical devices. The growing global elderly population, as well as increased incidences in chronic diseases, is producing exponential requirements for fast and safe medical solutions, translating to increased demand for high-performance polymers. The advancement of healthcare infrastructure in emerging economies is fostering increased use of medical polymers in medical disposables and drug delivery systems. New technological advancements include bioresorbable polymers and antimicrobial polymers, and the enhancement of the use of medical polymers for implementation in a variety of medical applications. Due to challenges regarding regulatory standards and the desire to create safer materials, the industry will continue to experience ongoing research and development.

The medical plastics segment is estimated to account for the largest share of the medical polymer market during the forecast period.

The medical plastics segment is estimated to account for the largest share in the medical polymer market due to their affordability, versatility, and extensive use in medical devices. Medical plastics are biocompatible, chemically resistant, and able to withstand sterilization processes, enabling manufacturers to create syringes, catheters, IV bags, surgical equipment and devices, and analytical and diagnostic devices. Medical plastics weigh little, can be molded into shapes and forms, are able to be manufactured into complex designs and forms, and are rigid yet safe for patients. The healthcare profession is continuing to call for adoption of single-use and disposable medical devices to reduce cross-contamination and healthcare-associated infections (HCAIs) in hospitals. Hence, the demand for medical plastics will only continue to grow. Plastics are evolving through continued development of polymer formulations, such as antimicrobial or bioresorbable plastics, which significantly increase functionality. In terms of functionality, usability, and compliance with healthcare regulations, medical plastics are taking the lead as the most common type of product within the medical polymer business.

The medical instruments & devices segment is the fastest-growing application in the medical polymer market during the forecast period.

The medical instruments & devices segment is the fastest growing and largest application of the medical polymer market due to increased demand for advanced, disposable medical tools that are minimally invasive. The growing global burden of chronic disease, aging population, and rise in surgical procedures are contributing to the demand for reliable, high-performing devices made of biocompatible polymers which have superior flexibility, strength, chemical resistance, and sterilization capability. Strong emphasis on patient safety and infection control has driven the increased clinical usage of single-use, polymer-based devices. The advancement in polymer technology, such as developments in bioresorbable and antimicrobial polymers, is also increasing device effectiveness.

Injection molding manufacturing technology is projected to be the fastest-growing segment in the medical polymer market during the forecast period.

Injection molding is projected to be the fastest-growing manufacturing technology due to its fast-paced production of consistent components and low costs. Injection-molded items are found in a variety of medical products, including syringes, surgical instruments or devices, housings, and diagnostic approaches. The injection molding method can be automated and expedited, all while rigorously adhering to hygiene and stringent quality controls. As the demand for disposable and miniaturized medical devices increases, injection molding offers scalability. The advancement of multilayered and micro-injection molded medical products has bolstered injection molding as the best option for mass production

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=211635984

Europe is estimated to be the second-largest region in the medical polymer market during the forecast period.

Europe is the second-largest market for medical polymer industry in 2025, The market in the region is driven by its sophisticated healthcare infrastructure, established regulatory environment, and high demand for innovative technology for medical devices and disposables. Active marketplaces in Europe consist of some of the very best medical device manufacturers and research facilities, which drives the pursuit of high-performance polymers in medical use. Increased spending on healthcare, an aging population, and high incidences of chronic disease are supporting strong demand for manufactured medical devices and disposable medical devices. The regulations set by the European Medicines Agency (EMA) and European Medical Device Regulations require the highest level of safety and quality for healthcare products, which creates demand for biocompatible and specialized polymers for medical use, discarding medical devices that may be harmful to patients. Sustainability initiatives throughout Europe and consideration of safe and environmentally sustainable medical products also drive the expansion of recyclable polymer materials and biodegradable polymer materials.

Key Players

Leading players in the medical polymer companies BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese Corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US), among others

Investment Funding

The medical polymer market is seeing growing investment activity driven by demand for high-performance medical materials, advanced medical devices, drug delivery systems, precision polymer components, and specialized healthcare applications. Deal activity increased consistently during 2020–2025, rising from 2 deals in 2020 to 3 deals in 2021, 4 deals in 2022, and 5 deals each in 2023, 2024, and 2025. Funding activity saw significant fluctuations, rising from USD 355.3 million in 2020 to USD 1,030.5 million in 2022 and reaching a peak of USD 1,859.8 million in 2023. Funding then declined sharply to USD 415.4 million in 2024 and USD 32.5 million in 2025. The sharp decline in funding value in 2025, despite deal activity remaining stable at 5 deals, indicates a shift toward smaller-scale investments and strategic transactions rather than a reduction in overall investor interest. Investment continues to focus on specialized medical polymer formulations, biocompatible and high-performance materials, precision plastic components, advanced processing technologies, manufacturing capacity expansion, and healthcare applications. These investments are supporting the development of application-specific medical polymers and strengthening production capabilities to meet the evolving requirements of medical devices, healthcare products, and drug delivery systems.

Revenue Shift

The medical polymer market is experiencing a shift from conventional commodity-oriented medical plastics toward higher-value, application-specific polymer solutions designed to meet increasingly stringent performance, safety, and regulatory requirements. Growth opportunities are expanding across advanced medical devices, drug delivery systems, minimally invasive instruments, implantable components, medical packaging, and diagnostic applications. High-performance and engineering polymers, such as PEEK, PTFE, PPSU, polycarbonate, polyamide, and specialty elastomers, are gaining adoption where high chemical resistance, sterilization stability, mechanical strength, biocompatibility, and dimensional stability are required. In parallel, polymer applications are expanding toward increasingly sophisticated healthcare products, including implantable devices, wearable and diagnostic devices, advanced drug delivery systems, and precision components for minimally invasive procedures. The increasing emphasis on lightweight medical devices, patient safety, product miniaturization, sterilization compatibility, and customized material performance is expected to shift future revenue toward higher-performance, specialty, and application-specific medical polymer solutions.

Mergers and Acquisitions

Mergers, acquisitions, and strategic consolidation remained active across the medical polymer and medical plastics industry as companies sought to expand their specialty material portfolios, strengthen healthcare manufacturing capabilities, and gain access to advanced medical device and component technologies. In August 2024, DuPont completed the acquisition of Donatelle Plastics for USD 313 million, expanding its capabilities in precision plastic components and contract manufacturing for medical devices and strengthening its presence across healthcare and medical polymer-intensive applications. In August 2023, DuPont announced the acquisition of Spectrum Plastics Group, a manufacturer of specialty medical devices and components, further expanding its exposure to high-growth healthcare markets and increasing the contribution of healthcare-related businesses to its portfolio. These transactions demonstrate the continued consolidation of the medical polymer value chain, particularly around specialty polymers, precision plastic processing, medical components, and contract manufacturing. The trend is expected to support the development of integrated material-to-component capabilities and strengthen the position of companies serving high-value medical device, drug delivery, diagnostic, and healthcare applications.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=211635984

Browse Adjacent Market: Resins & Polymers Market Research Reports &Consulting

See More Latest Resins & Polymers Industry Reports:

PTFE Market by Form, Application, End-use Industry (Chemical & Industrial Processing, Automotive & Aerospace, Electrical & Electronics, Building & Construction, Consumer Goods), and Region - Global Forecast to 2031

Medical Tubing Market by Material (Plastics, Rubbers, Specialty Polymers), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems), Structure (Single-Lumen, Multi-Lumen, Co-Extruded, Braided) - Global Forecast To 2031

Polycarbonate Resin Market by Application (Electrical & Electronics, Optical Media, Construction, Consumer, Automotive, Packaging, Medical), and Region (Asia Pacific, Europe, North America, Middle East & Africa) - Global Forecast to 2029

Polyamide Market by Type (Polyamide 6, Polyamide 66, Bio-Based & Specialty Polyamide), Application (Engineering Plastics (Automotive, Electrical & Electronics, Wire & Cable), and Fiber (Textile, Industrial, Carpet), and Region - Global Forecast to 2031

EPDM Market by Manufacturing Process (Solution Polymerization Process, Slurry/Suspension Process, Gas-Phase Polymerization Process), Application (Automotive, Building & Construction, Plastic Modifications, Tires & Tubes, Wire & Cables, Lubricant Additives, Other Applications), and Region - Global Forecast to 2031

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/medical-polymer-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/medical-polymer.asp